[ACRX] QoQ Quarter Result on 30-Sep-2011 [#Q3]

Stock
[ACRX] AcelRx Pharmaceuticals, Inc.
Announcement Date
08-Nov-2011
Financial Year
2011
Quarter
30-Sep-2011 [#Q3]
Profit Trend
QoQ- -20.95%
YoY- -59.98%
Quarter Report
ACRX's Result
ACRX's Financial Summary
View:
Show?
Quarter Result
30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 CAGR
Revenue 224 329 624 408 40 0 0 -
PBT -6,596 -7,065 -20,101 -5,761 -4,607 -3,204 -14,344 -40.45%
Tax 248 519 -13,728 356 144 -331 -10,819 -
NP -7,194 -7,065 -6,372 -5,761 -4,763 -3,204 -3,523 61.02%
Tax Rate - - - - - - - -
Total Cost 7,418 7,394 6,996 6,169 4,803 3,204 3,523 64.35%
Ratio Analysis
30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 CAGR
NP Margin -3,211.61 -2,147.42 -1,021.15 -1,412.01 -11,907.50 0.00 0.00 -
Per Share
30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 CAGR
EPS -6.98 -7.21 -6.50 -5.92 -4.92 -5.97 -6.56 4.22%
EPS Diluted -6.98 -7.21 -6.50 -5.92 -4.92 -5.97 -6.56 4.22%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.